logo-loader

ImmunoPrecise Antibodies opens new office in Cambridge, MA

Last updated: 10:04 14 Feb 2019 EST, First published: 09:50 14 Feb 2019 EST

office
ImmunoPrecise is a Canadian contract research organization focused on antibody discovery and manufacturing

ImmunoPrecise Antibodies Ltd (OTCMKTS:IPATF) (CVE:IPA) said Thursday it has opened a new office in Cambridge, Massachusetts.

The office will be staffed at first for sales and business development and will take advantage of the Cambridge area’s focus on biotech and pharmaceuticals.

READ: Immunoprecise Antibodies reports 2Q revenue doubled on increased capacity, European expansion

“Establishing a base in the Boston/ Cambridge area, a powerhouse for biotech and pharma, is a strategic next step for ImmunoPrecise. We already have a strong base of both European and US clients, and this move will help us enhance and grow our Boston area business and relationships,” said Jennifer Bath, CEO of ImmunoPrecise, in a statement.

Based in Victoria, British Columbia, ImmunoPrecise is a Canadian contract research organization focused on antibody discovery and manufacturing.

ImmunoPrecise shares slipped 1.67% to hit C$0.59 in morning trade on Thursday.

Contact Ellen Kelleher at ellen@proactiveinvestors.com

ImmunoPrecise Antibodies reveals 39% growth in 1Q revenue, initiates...

ImmunoPrecise Antibodies Ltd. (TSX-V:IPA) (OTCQB:IPATF) CEO Dr Jennifer Bath tells Proactive the technology platform company reported revenue increases by 39%, to $3.8 million in its first quarter financials, while the company initiates its pre-clinical coronavirus vaccine study. Bath says new...

on 09/30/2020